Literature DB >> 12434092

[Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].

J F Cadranel.   

Abstract

Mesh：

Year:  2002        PMID： 12434092

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  17 in total

Review 1.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

3.  Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?

Authors:  Masato Yoneda; Kento Imajo; Atsushi Nakajima
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

Review 4.  Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Jiulian Gu; Shousheng Liu; Shuixian Du; Qing Zhang; Jianhan Xiao; Quanjiang Dong; Yongning Xin
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

5.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

6.  Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.

Authors:  Masato Yoneda; Hironori Mawatari; Koji Fujita; Kyoko Yonemitsu; Shingo Kato; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Yasunobu Abe; Kensuke Kubota; Satoru Saito; Tomoyuki Iwasaki; Yasuo Terauchi; Shinji Togo; Shiro Maeyama; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2007-05-25       Impact factor: 7.527

7.  Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.

Authors:  Masato Yoneda; Kento Imajo; Yuichiro Eguchi; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Masafumi Ono; Yasuaki Suzuki; Takumi Kawaguchi; Noriaki Aoki; Michio Sata; Kazuyuki Kanemasa; Yutaka Kohgo; Toshiji Saibara; Kazuaki Chayama; Yoshito Itoh; Toshikazu Yoshikawa; Keizo Anzai; Kazuma Fujimoto; Takeshi Okanoue; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2012-11-27       Impact factor: 7.527

8.  Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.

Authors:  Philippe Halfon; Marc Bourlière; Guillaume Pénaranda; Romaric Deydier; Christophe Renou; Danielle Botta-Fridlund; Albert Tran; Isabelle Portal; Isabelle Allemand; Alessandra Rosenthal-Allieri; Denis Ouzan
Journal:  Comp Hepatol       Date:  2005-07-11

9.  Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).

Authors:  Masato Yoneda; Takashi Uchiyama; Shingo Kato; Hiroki Endo; Koji Fujita; Kyoko Yoneda; Hironori Mawatari; Hiroshi Iida; Hirokazu Takahashi; Hiroyuki Kirikoshi; Masahiko Inamori; Yuichi Nozaki; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Shiro Maeyama; Mina Sagara; Hiroyuki Aburatani; Tatsuhiko Kodama; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2008-11-14       Impact factor: 3.067

10.  Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis.

Authors:  Yuji Ogawa; Kento Imajo; Masato Yoneda; Takaomi Kessoku; Wataru Tomeno; Yoshiyasu Shinohara; Shingo Kato; Hironori Mawatari; Yuichi Nozaki; Koji Fujita; Hiroyuki Kirikoshi; Shin Maeda; Satoru Saito; Koichiro Wada; Atsushi Nakajima
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.